Breaking News Instant updates and real-time market news.

CAT

Caterpillar

$121.37

0.89 (0.74%)

, ADI

Analog Devices

$83.84

1.5 (1.82%)

10:13
09/16/17
09/16
10:13
09/16/17
10:13

Caterpillar, Analog among few stocks rising on earnings surprises, Barron's says

Until recently, companies that beat quarterly earnings estimates could routinely expect shares to rise, but not anymore, Jack Hough writes in this week's edition of Barron's. Although there is a shortage of true upside surprisers, Hough says there are still some, with Align Technology (ALGN), Analog Services (ADI), Caterpillar (CAT), E-Trade Financial (ETFC) and Red Hat (RHT) among those who beat earnings and revenue estimates and enjoyed quick share price gains as a result, which should bode well for future performance.Reference Link

CAT

Caterpillar

$121.37

0.89 (0.74%)

ADI

Analog Devices

$83.84

1.5 (1.82%)

ETFC

E-Trade

$41.06

0.34 (0.83%)

ALGN

Align Technology

$184.50

-0.36 (-0.19%)

RHT

Red Hat

$107.30

-0.44 (-0.41%)

  • 25

    Sep

CAT Caterpillar
$121.37

0.89 (0.74%)

09/14/17
BMOC
09/14/17
NO CHANGE
BMOC
Caterpillar price target raised to $150 from $130 at BMO Capital
Following Caterpillar's Analyst Day, BMO Capital analyst Joel Tiss believes that the company's " revamped strategy focused on improving the customer experience should pay dividends." The analyst estimates that the company's EPS can reach $9-$11 if its generates its "baseline revenue" figure of $55B. He raised his price target on the shares to $150 from $130 and keeps an Outperform rating on the stock.
09/06/17
GHSC
09/06/17
INITIATION
Target $120
GHSC
Neutral
Caterpillar initiated with a Neutral at Seaport Global
Seaport Global analyst Michael Shlisky initiated Caterpillar with a Neutral and $120 price target citing the recent run in the stock.
09/14/17
STFL
09/14/17
NO CHANGE
Target $125
STFL
Hold
Stifel 'encouraged' by Caterpillar analyst day, keeps stock at Hold
After attending Caterpillar's analyst day meeting, Stifel analyst Stanley Elliott said he came away "encouraged," though he notes expectations into the event were high and he would have hoped for a few more specifics. He keeps a Hold rating and $125 price target on Caterpillar shares following the event.
09/06/17
09/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Caterpillar (CAT) initiated with a Neutral at Seaport Global. 2. Liberty Global (LBTYA) initiated with a Buy at Deutsche Bank. 3. TransUnion (TRU) initiated with a Buy at SunTrust. 4. Inovio (INO) initiated with a Buy at Citi. 5. e.l.f. Beauty (ELF) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ADI Analog Devices
$83.84

1.5 (1.82%)

09/12/17
JPMS
09/12/17
NO CHANGE
JPMS
JPMorgan lays out iPhone content winners and losers into launch event
JPMorgan analyst Harlan Sur believes Apple's (AAPL) launch event today will be positive for Broadcom (AVGO) and Qorvo (QRVO) as well as Micron (MU) and Intel (INTC). The analyst sees content gains by Broadcom in wireless charging, touch controller, Wi-Fi/Bluetooth and GPS connectivity, and by Qorvo in low band power amplifier duplexers share and antenna tuning. Other companies with significant Apple exposure that would benefit from increased unit sales and/or modest content gains include Intel, Skyworks (SWKS), Knowles (KN), Micron, Cypress Semiconductor (CY), NXP Semiconductors (NXPI) and Texas Instruments (TXN), Sur tells investors in a research note. The analyst sees Analog Devices' (ADI) blended content at Apple declining as he believes the company will not be the touch controller for the OLED-version of the iPhone.
08/31/17
NOMU
08/31/17
UPGRADE
Target $80
NOMU
Neutral
Analog Devices upgraded to Neutral from Reduce at Nomura Instinet
Nomura Instinet analyst Romit Shah upgraded Analog Devices to Neutral and raised its price target to $80 from $72.50 following Q3 resutls and guidance. The analyst said Q3 results were "solid" and guidance was based in part on improved profitability. Shah also said the "speedy" appointment of Prashanth Mahendra-Rajah as CFO is a positive as he has a solid track record of driving shareholder value and is well regarded.
06/15/17
RAJA
06/15/17
INITIATION
RAJA
Market Perform
Analog Devices initiated with a Market Perform at Raymond James
Raymond James analyst Chris Caso resumed coverage on Analog Devices with a Market Perform saying earnings and cash flow post linear are in line peers.
06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Analog Devices to forecast double digit EPS growth, says SunTrust
SunTrust analyst William Stein expects Analog Devices to unveil "a new business model" that will include EPS growth of at least 10% at its Analyst Day next Tuesday. He thinks that more investors will believe that the stock deserves its current premium following the Analyst Day. Stein keeps a $101 price target and a Buy rating on the shares.
ETFC E-Trade
$41.06

0.34 (0.83%)

07/24/17
RHCO
07/24/17
NO CHANGE
RHCO
E-Trade price target raised to $49 from $43 at SunTrust
SunTrust analyst Douglas Mewhirter increased his price target on E-Trade after the company reported Q2 results that he called "strong." The analyst raised his EPS estimates for the company and keeps a Buy rating on the shares.
07/21/17
WELS
07/21/17
NO CHANGE
WELS
E-Trade shares should be up more, says Wells Fargo
Wells Fargo believes that E-Trade's stock should be up more after the company reported stronger than expected Q2 results and announced what the firm calls "an aggressive capital return plan." Wells increased its longer term EPS estimates for the company by more than 10% and keeps an Outperform rating on the shares.
07/13/17
07/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HP Inc. (HPQ), 3D Systems (DDD), and Stratasys (SSYS) were initiated with a Neutral at Susquehanna. 2. Danaher (DHR) initiated with a Market Perform at Wells Fargo. 3. E-Trade (ETFC) and TD Ameritrade (AMTD) were initiated with a Buy at Rosenblatt, while Charles Schwab (SCHW) was initiated with a Neutral. 4. C&J Energy Services (CJ) initiated with a Buy at Jefferies. 5. BIO-key (BKYI) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/17
LEHM
09/08/17
INITIATION
Target $45
LEHM
Overweight
E-Trade initiated with an Overweight at Barclays
Barclays analyst Jeremy Campbell started E-Trade with an Overweight rating and $45 price target. The analyst initiated U.S. Brokers, Asset Managers & Exchanges with a Neutral industry view.
ALGN Align Technology
$184.50

-0.36 (-0.19%)

09/11/17
PIPR
09/11/17
NO CHANGE
Target $200
PIPR
Overweight
Align Technology price target raised to $200 from $188 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology to $200 after attending the Invisalign GP Summit this past weekend. The analyst left the meeting feeling the company's iTero is much more vital to the general practitioner workflow than previously thought and that moving teeth is growing into an increasingly important piece of the GP practice. He calls Align a "one of a kind" name and tells investors to build positions at current levels. O'Brien keeps an Overweight rating on the shares.
09/15/17
GSCO
09/15/17
NO CHANGE
Target $210
GSCO
Buy
Align Technology price target raised to $210 from $185 at Goldman Sachs
Goldman analyst Robert Jones raised Align Technology's price target to $210 to reflect an increased multiple for the group and improved traction in the teen segment and a push into international markets. Shares of Align Technology are Buy rated.
09/06/17
PIPR
09/06/17
NO CHANGE
PIPR
Overweight
Align patent expirations to have minimal impact, says Piper Jaffray
About 40 of Align Technology's patents are about to expire, which will allow competitors for the first time to plan cases using computer assistance, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst, however, believes only a "modest part" of Align's revenue, maybe $20M-$30M, could be at risk. He still sees the company growing in its traditional range of 15%-25% on the top-line and encourages investors to build positions in the name. Olson raised his price target for Align Technology shares to $188 from $176 and keeps an Overweight rating on the name.
08/18/17
WBLR
08/18/17
NO CHANGE
WBLR
Outperform
Align selloff on ClearCorrect takeover overdone, says William Blair
William Blair analyst John Kreger believes the selloff yesterday in shares of Align Technology after Straumann announced that it was acquiring ClearCorrect is overdone. The analyst does not think Straumann buying ClearCorrect affects Align's growth outlook He continues to expect Align's success at migrating traditional orthodontics to clear aligners will attract new competitors. Kreger keeps an Outperform rating on Align shares.
RHT Red Hat
$107.30

-0.44 (-0.41%)

09/06/17
MOFT
09/06/17
INITIATION
Target $135
MOFT
Buy
Red Hat initiated with a Buy at MoffettNathanson
MoffettNathanson analyst Adam Holt initiated Red Hat with a Buy and a $135 price target.
09/08/17
KEYB
09/08/17
INITIATION
Target $121
KEYB
Overweight
Red Hat resumed with an Overweight at KeyBanc
KeyBanc analyst Alex Kurtz resumed coverage of Red Hat with an Overweight rating and $121 price target. The analyst believes the company's products continue to have a strong secular position.
09/05/17
09/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Owens-Illinois (OI) initiated with a Neutral at UBS. 2. Akamai (AKAM) initiated with a Neutral at Credit Suisse. 3. Zealand Pharma (ZEAL) was initiated with a Buy at Needham and Guggenheim while being initiated with an Overweight at Morgan Stanley. 4. YogaWorks (YOGA) was initiated with an Outperform at Cowen, an Overweight at Stephens, and a Buy at Roth Capital and Guggenheim. 5. Red Hat (RHT) initiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/17
JMPS
09/13/17
NO CHANGE
Target $122
JMPS
Outperform
Red Hat price target raised to $122 after open source event at JMP Securities
After attending the Open Source Summit North America, JMP Securities analyst Greg McDowell said open source is not only growing but accelerating "exponentially," adding that he believes Red Hat has been and should continue to be a beneficiary of the trend. Given that the summit left him feeling better about Red Hat's prospects, he raised his price target on the stock to $122 from $107. McDowell keeps an Outperform rating on Red Hat shares ahead of the company's earnings report on September 25.

TODAY'S FREE FLY STORIES

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary  »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

HII

Huntington Ingalls

$242.12

5.24 (2.21%)

17:21
01/19/18
01/19
17:21
01/19/18
17:21
Hot Stocks
Huntington Ingalls awarded $125.2M government contract modification »

Huntington Ingalls Inc. -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 21

    Feb

BAESY

BAE Systems

$33.30

0.18 (0.54%)

, GD

General Dynamics

$209.10

1.3 (0.63%)

17:20
01/19/18
01/19
17:20
01/19/18
17:20
Hot Stocks
BAE Systems, General Dynamics awarded $237.6M government contract modification »

BAE Systems (BAESY) San…

BAESY

BAE Systems

$33.30

0.18 (0.54%)

GD

General Dynamics

$209.10

1.3 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SYRS

Syros Pharmaceuticals

$10.80

0.27 (2.56%)

17:17
01/19/18
01/19
17:17
01/19/18
17:17
Syndicate
Breaking Syndicate news story on Syros Pharmaceuticals »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$87.81

0.96 (1.11%)

17:13
01/19/18
01/19
17:13
01/19/18
17:13
Hot Stocks
Wintrust Financial raises its minimum wage to $15 per hour »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TWTR

Twitter

$23.66

-0.38 (-1.58%)

17:07
01/19/18
01/19
17:07
01/19/18
17:07
Hot Stocks
Twitter says has identified more IRA and automated Russia-based accounts »

In a statement on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ITEK

Inotek Pharmaceuticals

17:04
01/19/18
01/19
17:04
01/19/18
17:04
Hot Stocks
Boxer Capital reports 5.3% passive stake in Rocket Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIS

Oil States

$32.80

0.35 (1.08%)

17:03
01/19/18
01/19
17:03
01/19/18
17:03
Syndicate
Breaking Syndicate news story on Oil States »

Oil States files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

, QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

16:43
01/19/18
01/19
16:43
01/19/18
16:43
Hot Stocks
Broadcom receives second request from FTC for proposed Qualcomm deal »

Broadcom (AVGO) announced…

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TRNC

tronc

$19.53

0.3 (1.56%)

16:37
01/19/18
01/19
16:37
01/19/18
16:37
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, WSJ says »

Ross Levinsohn, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AP

Ampco-Pittsburgh

$14.20

0.15 (1.07%)

16:35
01/19/18
01/19
16:35
01/19/18
16:35
Syndicate
Breaking Syndicate news story on Ampco-Pittsburgh »

Ampco-Pittsburgh files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CG

Carlyle Group

$24.35

-0.05 (-0.20%)

, UBSH

Union Bankshares

$38.79

0.54 (1.41%)

16:33
01/19/18
01/19
16:33
01/19/18
16:33
Hot Stocks
Carlyle Group reports 6% passive stake in Union Bankshares »

In a regulatory filing,…

CG

Carlyle Group

$24.35

-0.05 (-0.20%)

UBSH

Union Bankshares

$38.79

0.54 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ANDX

Andeavor Logistics

$52.52

0.12 (0.23%)

16:31
01/19/18
01/19
16:31
01/19/18
16:31
Hot Stocks
Andeavor Logistics raises quarterly cash distribution to $1.00 per unit »

The fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

16:30
01/19/18
01/19
16:30
01/19/18
16:30
Options
Preliminary option volume of 22.8M today »

Preliminary option volume…

TRNC

tronc

$19.53

0.3 (1.56%)

16:26
01/19/18
01/19
16:26
01/19/18
16:26
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, DJ says »

Dow Jones added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$0.27

0.0285 (11.88%)

16:25
01/19/18
01/19
16:25
01/19/18
16:25
Conference/Events
Arcadia Biosciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.